A pioneer of the pharmaceutical industry in Tunisia, the “Society of Pharmaceutical Industries of Tunisia – SIPHAT” ensures the development, manufacturing and marketing of drugs for human use in their various forms.

For its work method, SIPHAT set up a well thought-out policy of production, prospection, marketing and investment. At the same time, the company undertook, with the assistance of a highly qualified and experimented team, to establish a strategy of planning and implementation.

Since its creation, SIPHAT wants to create customer loyalty in Tunisia and abroad.

In the Tunisian market, SIPHAT distinguishes itself by:

1. A specific and privileged position as the oldest member of the pharmaceutical industry, present in the market since 1970
2. A rich and varied product range: 141 officinal products; 109 hospital products, 135 patent medicines and 15 therapeutic categories
3. An ultra-professional team of researchers highly qualified and experimented in the sector.
4. The fact of being the only Tunisian firm that has the equipment required for producing bulk solutions packaged in bags. Therefore, SIPHAT covers a major part of the needs of the national market.
5. Holding participations in the capital of other pharmaceutical firms such as: SAIPH, PFIZER, PIERRE FABRE, and TECHNOPOLE SIDI THABET.

SIPHAT is not just a manufacturer but above all a responsible manufacturer.